# Clinical Trial Site Feasibility

## Enterprise Project Bible for Snowflake Warehousing, dbt Transformations, and Streamlit Applications

## Executive Summary

Clinical trial site feasibility is a critical upstream activity in drug development, directly influencing trial timelines, cost efficiency, patient recruitment success, and regulatory outcomes. Poor site selection leads to under-enrollment, protocol deviations, and costly amendments. This project defines an enterprise-grade analytics platform designed to systematically evaluate, score, and monitor clinical trial sites using structured, semi-structured, and external real-world data.

The platform is built on Snowflake as the core data warehouse, dbt for governed transformation and semantic modeling, and Streamlit for interactive analytics applications. It supports feasibility assessments across therapeutic areas, geographies, and trial phases, while meeting stringent regulatory, privacy, and audit requirements common to life sciences organizations.

This Project Bible serves as a single source of truth for architecture, data modeling, governance, and delivery strategy. It is written to be implementation-ready for a cross-functional data engineering, analytics, and clinical operations team.

## Business Context and Problem Statement

Clinical development teams face persistent challenges when selecting trial sites. Decisions are often based on fragmented historical data, investigator reputation, and manual feasibility questionnaires. These approaches are slow, subjective, and poorly scalable across global portfolios.

Key business problems include limited visibility into historical site performance across sponsors and studies, inability to integrate operational metrics with external signals such as epidemiology or real-world evidence, and lack of standardized scoring frameworks across therapeutic areas. Additionally, feasibility data is often locked in spreadsheets, emails, or vendor systems with minimal governance.

The absence of a centralized, analytics-driven feasibility platform results in delayed study start-up, increased screen failure rates, and higher operational risk. This project addresses these issues by creating a governed, reusable, and analytics-first data platform that embeds feasibility intelligence into clinical planning workflows.

## Goals and Success Criteria

The primary goal is to enable data-driven, auditable, and repeatable clinical trial site feasibility decisions. Success is defined by both technical outcomes and business impact.

From a business perspective, the platform must reduce site selection cycle time, improve enrollment predictability, and increase the proportion of high-performing sites activated per study. From a technical perspective, the platform must support multi-study scalability, incremental data ingestion, and governed self-service analytics.

Success criteria include consistent site feasibility scoring across studies, demonstrable reuse of historical site performance data, stable data pipelines with defined SLAs, and adoption of Streamlit applications by clinical operations and feasibility teams.

## Stakeholders and Personas

This initiative serves multiple stakeholder groups with distinct needs and risk profiles.

Clinical operations leaders require high-level feasibility summaries, scenario comparisons, and audit-ready justification for site decisions. Feasibility managers and study planners need detailed site-level metrics, historical performance trends, and drill-down capabilities. Data science and analytics teams need clean, well-modeled datasets for advanced modeling such as enrollment forecasting. IT, data engineering, and compliance teams require strong governance, security, and lineage.

The architecture is designed to balance flexibility for analytics with strict controls appropriate for regulated environments.

## Data Source Landscape

The feasibility platform integrates internal, partner, and external data sources.

Internal sources include clinical trial management systems containing site activation dates, enrollment metrics, protocol deviations, and close-out timelines. Electronic data capture systems contribute screening and enrollment events. Feasibility questionnaires provide structured and semi-structured responses about site capabilities and interest.

External sources include investigator databases, epidemiology datasets, disease prevalence statistics, and potentially real-world data vendors providing patient population insights. Vendor performance data from CROs may also be included where contractual access exists.

ASSUMPTION: Source system APIs or batch exports are available and contractually permitted for analytical use. If not, ingestion frequency and granularity may be constrained.

## Architecture Overview

The platform follows a layered Snowflake architecture aligned to enterprise data engineering best practices.

Raw ingestion occurs in Snowflake stages using a combination of cloud storage integration and Snowflake-native ingestion patterns. Data is stored in raw schemas with minimal transformation to preserve source fidelity.

Cleansed and conformed data is produced through dbt-managed transformations, applying standardization, validation, and business logic. These models form the canonical representation of sites, investigators, studies, and performance metrics.

Analytics-ready marts are built on top of conformed layers, optimized for feasibility scoring, trend analysis, and Streamlit consumption. Streamlit applications run directly against Snowflake, ensuring low-latency access and eliminating data duplication.

Security, governance, and observability are embedded across layers rather than treated as afterthoughts.

## Snowflake Data Warehousing Strategy

Snowflake is selected for its scalability, separation of storage and compute, native support for semi-structured data, and strong security features relevant to life sciences.

Warehouses are segregated by workload, typically separating ingestion, transformation, and analytics usage to control cost and performance. Time-travel and fail-safe capabilities support auditability and recovery.

Data is organized into databases by domain, with schemas representing pipeline stages such as raw, staging, intermediate, and marts. This structure aligns cleanly with dbt conventions and simplifies lineage tracking.

## Stage Creation and Ingestion Design

Snowflake stages are used to ingest data from cloud object storage and external providers. External stages support direct access to controlled storage locations, while internal stages are used for smaller or transient loads.

File formats are explicitly defined for CSV, JSON, and Parquet sources, enabling schema evolution handling where required. Ingestion processes are designed to be incremental wherever possible, using metadata such as load timestamps or source system change flags.

ASSUMPTION: Change data capture is available for core operational systems. If not, incremental logic will rely on snapshot comparison and watermarking.

## Data Modeling Strategy

The modeling approach blends dimensional modeling with domain-driven design.

Core dimensions include Site, Investigator, Study, Geography, and Therapeutic Area. Fact tables capture enrollment events, site performance metrics, feasibility responses, and operational timelines.

This hybrid approach allows consistent cross-study reporting while preserving domain-specific nuances such as therapeutic area benchmarks or phase-specific expectations.

Slowly changing dimensions are explicitly managed to track changes in site attributes over time, supporting longitudinal performance analysis.

## dbt Transformation Framework

dbt is the backbone of transformation, testing, and documentation.

Models are organized into staging, intermediate, and mart layers, with clear dependencies and naming conventions. Business logic is centralized in dbt models rather than embedded in downstream applications, ensuring consistency across consumers.

Tests validate uniqueness, referential integrity, and accepted value ranges for critical fields such as enrollment counts and activation dates. Documentation generated by dbt serves as living technical reference and supports onboarding.

Version control and CI pipelines enforce code quality and reduce deployment risk.

## Feasibility Scoring and Analytics Framework

A standardized feasibility scoring framework is implemented at the analytics layer.

Scores combine historical performance, site capacity indicators, investigator experience, and external population signals. Weightings are configurable by study or therapeutic area, allowing flexibility without compromising governance.

The scoring logic is transparent and auditable, avoiding black-box approaches unless explicitly approved. This transparency is essential for regulatory confidence and internal trust.

ASSUMPTION: Initial scoring models are rules-based. Advanced machine learning models may be introduced in later phases once sufficient historical data quality is established.

## Streamlit Application Layer

Streamlit is used to deliver interactive feasibility applications directly on Snowflake.

Applications include site comparison dashboards, geographic heatmaps, enrollment trend visualizations, and scenario analysis tools. Users can filter by study attributes, simulate different weighting strategies, and export results for downstream workflows.

Authentication and authorization are integrated with Snowflake roles to ensure users only see permitted data. Streamlit apps are designed as decision-support tools, not record systems, reinforcing Snowflake as the system of record.

## Governance, Security, and Compliance

Given the regulated nature of clinical data, governance is a first-class concern.

Role-based access control restricts data access by function and study. Sensitive attributes such as investigator contact details are masked where not required. Audit logs track data access and transformation changes.

The platform is designed to support compliance with GxP expectations, data privacy regulations, and internal SOPs. While Snowflake is not itself a validated system, controls are implemented to support validation of analytical outputs where required.

## Data Quality and Monitoring

Data quality is addressed through proactive validation rather than reactive remediation.

Key quality dimensions include completeness, timeliness, consistency, and plausibility. dbt tests catch issues early in the pipeline, while monitoring dashboards track pipeline health and freshness.

Operational alerts notify data engineering teams of ingestion failures or threshold breaches, reducing downstream impact.

## Performance and Cost Optimization

Performance is managed through warehouse sizing, query optimization, and caching strategies.

Cost controls include auto-suspend warehouses, workload isolation, and monitoring of high-cost queries. dbt models are materialized strategically as views or tables based on usage patterns.

These practices ensure the platform remains sustainable as data volume and user adoption grow.

## Testing and Deployment Strategy

Testing spans unit tests in dbt, integration tests for ingestion pipelines, and user acceptance testing for Streamlit applications.

Deployments follow environment promotion from development to test to production, with infrastructure-as-code principles applied where feasible. Rollbacks are supported through version control and Snowflake time-travel.

## Risks, Assumptions, and Constraints

Key risks include data availability delays, inconsistent source system definitions, and organizational resistance to standardized scoring. These are mitigated through stakeholder engagement and phased rollout.

ASSUMPTION: Business owners are aligned on feasibility definitions and success metrics. Misalignment would require additional governance forums.

Constraints include regulatory requirements, vendor data licensing, and varying maturity of source systems across regions.

## Roadmap and Future Enhancements

Future phases may include predictive enrollment modeling, integration with protocol design tools, and incorporation of real-world evidence datasets.

Advanced analytics such as machine learning-based site recommendation engines can be layered on once data maturity and trust are established.

## Conclusion

This Clinical Trial Site Feasibility platform provides a robust, scalable, and governed foundation for improving one of the most impactful decisions in clinical development. By combining Snowflake, dbt, and Streamlit in a cohesive architecture, the organization gains not just dashboards, but an enterprise capability that embeds data-driven reasoning into clinical planning.

The design emphasizes realism, auditability, and long-term reuse, ensuring the platform evolves alongside the clinical portfolio rather than becoming another isolated analytics solution.
